Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mitzner

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Liver|September 11, 2002
Albumin dialysis: single pass vs. recirculation (MARS)P Peszynski, S Klammt, E Peters, et al.
Clinical Nephrology|November 19, 2010
Atypical electrolyte kinetics during an emergency dialysis session in a patient with Leriche syndromeS Koball, H Hickstein, A Führer, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 16, 2005
[Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters]S Mitzner, S Klammt, J Stange, et al.
Zeitschrift Fur Gastroenterologie|October 11, 2005
Albumin-bound substances--a new target in liver failure therapyS Mitzner, J Stange, S Klammt, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1995
Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?S Mitzner, J Stange, K Pichel, et al.
Zeitschrift Fur Gastroenterologie|October 11, 2005
Albumin binding capacity (ABiC) is reduced in commercially available human serum albumin preparations with stabilizersS Klammt, B Brinkmann, S Mitzner, et al.
Metabolic Brain Disease|February 27, 2003
Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS--a review of clinical, biochemical, and electrophysiological dataS Mitzner, J Loock, P Peszynski, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1993
Prolonged biochemical and morphological stability of encapsulated liver cells--a new methodJ Stange, S Mitzner, H Dautzenberg, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1995
Primary or established liver cells for a hybrid liver? Comparison of metabolic featuresJ Stange, S Mitzner, M Strauss, et al.
Zeitschrift Fur Gastroenterologie|October 11, 2005
Influence of albumin dialysis (MARS) on neuronal network activity in vitro--early resultsJ Loock, J Stange, S Mitzner, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Liver|September 11, 2002
Albumin dialysis: single pass vs. recirculation (MARS)P Peszynski, S Klammt, E Peters, et al.
Clinical Nephrology|November 19, 2010
Atypical electrolyte kinetics during an emergency dialysis session in a patient with Leriche syndromeS Koball, H Hickstein, A Führer, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 16, 2005
[Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters]S Mitzner, S Klammt, J Stange, et al.
Zeitschrift Fur Gastroenterologie|October 11, 2005
Albumin-bound substances--a new target in liver failure therapyS Mitzner, J Stange, S Klammt, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1995
Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?S Mitzner, J Stange, K Pichel, et al.
Zeitschrift Fur Gastroenterologie|October 11, 2005
Albumin binding capacity (ABiC) is reduced in commercially available human serum albumin preparations with stabilizersS Klammt, B Brinkmann, S Mitzner, et al.
Metabolic Brain Disease|February 27, 2003
Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS--a review of clinical, biochemical, and electrophysiological dataS Mitzner, J Loock, P Peszynski, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1993
Prolonged biochemical and morphological stability of encapsulated liver cells--a new methodJ Stange, S Mitzner, H Dautzenberg, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1995
Primary or established liver cells for a hybrid liver? Comparison of metabolic featuresJ Stange, S Mitzner, M Strauss, et al.
Zeitschrift Fur Gastroenterologie|October 11, 2005
Influence of albumin dialysis (MARS) on neuronal network activity in vitro--early resultsJ Loock, J Stange, S Mitzner, et al.
Pageof 3